Exact Sciences (EXAS) has numerous competitors, given the large market for colorectal cancer screening.
Philips (PHG) expands its international footprint with the wide availability of VeriSight Pro 3D to several Hong Kong hospitals, strengthening its Diagnosis & Treatment segment.
On May 24, 2024, Elissa Charbonneau, Chief Medical Officer of Encompass Health Corp (NYSE:EHC), executed a sale of 10,000 shares of the company at a price of $85.02 per share.